Most Recent
Baker McKenzie has been accused of negligence in a cross claim by Chinese lender Aoyin, which faces a lawsuit by accounting giant PricewaterhouseCoopers for unpaid fees over advice related to a failed bid to launch a bank in Australia.
A plastic surgeon who was subjected to an "online tirade of criticism, negative reviews and abuse" by a former patient has won $450,000 in defamation damages.
The right approach to determining patentability of a computer-implemented invention is to first assess whether it is more than a mere scheme or business method, the Full Federal Court has been told in an appeal of a ruling backing IP Australia's revocation of two patents by plumbing company Repipe.
A Federal Court judge has criticised the liquidators of coal mining company Delta for waiting over two years to file insolvent trading proceedings against former directors when the same issues of solvency had already been raised in two other cases.
ABC reporter Louise Milligan has agreed to pay $79,000 to settle a defamation case by Liberal party MP Andrew Laming over what he called spiteful and accusatory tweets, but the agreement does not include an admission of liability, a court heard on Wednesday.
A unit of Oaktree Capital Management has been ordered to join all former shareholders of consumer brand wholesaler Marlin Brands as defendants in a case over the investment giant's $200 million acquisition of the company that alleges fraud or wilful deceit on the part of the sellers.
The Full Federal Court took a "radical" and unorthodox approach with far-reaching consequences by keeping Apple's competition dispute with Fortnite game maker Epic Games in Australia, the Silicon Valley giant has told the High Court.
The joint managers of Clive Palmer's Queensland Nickel refinery have been ordered to pay $26.6 million for natural gas charges owed, after a court rejected claims they did not need to repay the money because pipeline owners had breached their duties.
Swiss pharmaceutical company Biogen has filed another lawsuit accusing an Australian generic drug manufacturer of infringing the patent for its blockbuster multiple sclerosis drug Tecfidera.
Service station giant Ampol has lost its bid to force petrol station chain EG Fuel Co to allow it access to 87 Caltex sites so they can be rebranded to Ampol stations, with a judge finding it would cause EG “obvious disruption”.